Asthenozoospermia: Treatment & Causes 

What Is Asthenozoospermia?

For millions of couples across the GCC and Africa, the journey to parenthood can reveal unexpected challenges. When fertility investigations are undertaken, many couples are surprised to learn the issue lies with sperm motility — the ability of sperm to swim effectively. This condition is called asthenozoospermia, and it is one of the most common yet most treatable causes of male infertility.

Unlike azoospermia (where no sperm are present), asthenozoospermia means sperm exist in the ejaculate — but their movement is too slow, erratic, or absent to successfully reach and fertilise an egg. According to WHO 2021 reference values, a healthy semen sample should contain at least 30% progressively motile sperm. When this falls below that threshold on two separate analyses, asthenozoospermia is confirmed.

The most important message: asthenozoospermia is highly treatable. Whether through lifestyle changes, medical therapy, surgical correction, or assisted reproduction, the vast majority of affected men can still achieve biological fatherhood.

Grades, Types, and Causes

Sperm motility is classified into four grades — from Grade A (rapid, straight-line movement ideal for natural conception) through to Grade D (completely immotile sperm requiring IVF/ICSI). Understanding the grade guides treatment urgency and approach.

Asthenozoospermia occurs as an isolated condition (motility alone is impaired) or in combination with other sperm abnormalities, most notably OAT syndrome — oligoasthenoteratozoospermia — where low sperm count, poor motility, and abnormal morphology occur together.

Causes are varied. Structural and genetic causes include Primary Ciliary Dyskinesia (a genetic defect affecting the sperm tail), mitochondrial dysfunction (sperm need ATP energy from their midpiece to swim), and axonemal defects in the flagellar protein scaffold. Lifestyle causes — varicocele, heat exposure, smoking, obesity, alcohol use, and sedentary behaviour — are among the most common and most modifiable. Medical causes include genital tract infections (Chlamydia, E. coli, Mycoplasma), anti-sperm antibodies, hormonal imbalances, and poorly controlled diabetes. Oxidative stress, caused by an excess of reactive oxygen species (ROS) overwhelming the body’s antioxidant defences, is now recognised as a primary driver of asthenozoospermia across all these categories.

For patients in the GCC specifically, extreme occupational heat exposure in outdoor and construction roles, high regional rates of undiagnosed varicocele, dietary antioxidant deficiencies, and the Gulf’s high diabetes prevalence all represent significant and specific risk factors. Consanguineous marriages in Gulf populations also increase the risk of inherited conditions affecting sperm structure.

Diagnosis

Asthenozoospermia is typically asymptomatic — most men feel completely healthy and only discover the condition during fertility investigations. Diagnosis begins with Computer-Assisted Semen Analysis (CASA) — the gold standard — which objectively measures total and progressive motility, velocity, and linearity. Two separate analyses 4–6 weeks apart are required.

Further testing includes sperm DNA fragmentation assessment (high fragmentation correlates with poor motility and IVF outcomes), Reactive Oxygen Species (ROS) testing to quantify oxidative stress, anti-sperm antibody testing, a full hormone panel (FSH, LH, testosterone, prolactin, thyroid function), scrotal Doppler ultrasound to detect varicocele, and in selected cases, targeted genetic testing for inherited causes.

Treatment

Treatment depends entirely on the identified cause. For lifestyle-driven cases, targeted changes — quitting smoking, reducing alcohol, losing weight, adopting a Mediterranean-style diet, and avoiding scrotal heat — can produce meaningful motility improvements within 60–90 days.

Antioxidant supplement therapy is one of the most evidence-backed treatments for oxidative asthenozoospermia. Coenzyme Q10 (CoQ10) improves mitochondrial energy production and directly boosts swimming speed. L-Carnitine transports fatty acids into mitochondria for fuel. Selenium provides the structural integrity of the sperm flagellum. Vitamins C and E neutralise reactive oxygen species. Together, these supplements form a powerful first-line protocol for oxidative asthenozoospermia.

When infection is the cause, targeted antibiotic therapy can restore motility within weeks. Anti-sperm antibody cases respond to short-course corticosteroids. Hormonal causes are addressed with clomiphene citrate, FSH injections, or thyroid medication as appropriate.

When varicocele is identified, varicocelectomy — microsurgical ligation of the abnormal scrotal veins — is highly effective, with approximately 60–70% of men showing significant motility improvement after repair.

For moderate-to-severe cases, or when other treatments have been unsuccessful, assisted reproduction offers excellent outcomes. IUI (intrauterine insemination) is suitable for milder cases. IVF (in vitro fertilisation) is appropriate for significant motility impairment. IVF with ICSI (intracytoplasmic sperm injection) — where a single sperm is injected directly into an egg — completely bypasses the need for sperm to swim and is the definitive solution for severe asthenozoospermia. Pregnancy rates per ICSI cycle in women under 35 reach 45–60% at leading international centres.

Why GCC & African Patients Choose Sila Med Tour

Access to advanced diagnostics including CASA, ROS testing, and specialist andrological assessment remains limited across much of Africa and parts of the Gulf healthcare sector. Medical tourism through Sila Med Tour bridges this gap — connecting patients with internationally accredited fertility centres offering the full spectrum of asthenozoospermia care, often at 40–60% lower cost than equivalent Gulf private hospital treatment.

Every patient journey is handled with complete cultural sensitivity and confidentiality. We understand that male infertility carries deep social and emotional weight in GCC and African communities, and our entire service is built around respectful, discreet, expert support.

Take the First Step

Asthenozoospermia is not a dead end. For most men, the right diagnosis leads directly to the right treatment — and a family that was always within reach.

Contact Sila Med Tour today for a free, confidential consultation. 🌐 www.silamedtour.com | 📧 info@silamedtour.com Serving patients from Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, and across Africa.